An in vivo study on ICR-NOD/SCID mice showed that piperine significantly increased the antitumor effect of docetaxel on taxane-resistant prostate cancer and decreased MDR1 gene expression in the MDCK cell line [50]. This evidence concerns the gene ABCB1 and prostate carcinoma.